DCAF12 and HSPA1A May Serve as Potential Diagnostic Biomarkers for Myasthenia Gravis

Table 1

Baseline characteristics ( or %) among MG patients and their matched controls.

	Patients ()	Control ()	value
Sex
Males	3	3
Females	7	7
Age (years),			0.94
Anti-AChR-Ab-positive	9 (90%)	0
Anti-MUSK-Ab-positive	1 (10%)	0
Thymoma	2 (20%)	0
Symptom duration (months),		—

AChR: acetylcholine receptor; MuSK: muscle-specific tyrosine kinase.